Evidence map›Paper›PMID 30630988›Full record

ArticleHaematologica2019

Poor performance of D-dimer in excluding venous thromboembolism among patients with lymphoma and leukemia.

Aiham Qdaisat, Rawan Al Soud, Carol C Wu, Cristhiam M Rojas Hernandez, Jieli Li, Qing H Meng, Hikmat Abdel-Razeq, Sai-Ching Jim Yeung

Abstract readLetter
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aiham QdaisatDepartment of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rawan Al SoudDepartment of Emergency Medicine, King Hussein Cancer Center, Amman, Jordan.
Carol C WuDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cristhiam M Rojas HernandezDepartment of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jieli LiDepartment of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Qing H MengDepartment of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Hikmat Abdel-RazeqDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Sai-Ching Jim YeungDepartment of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA syeung@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fibrin Fibrinogen Degradation ProductsBlood Coagulation TestsDiagnosis, DifferentialHumansLeukemiaLymphomaReproducibility of ResultsROC CurveVenous ThromboembolismFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID30630988
PMCPMC6545857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.